Sutro Biopharma (STRO) Interest Coverage Ratio (2017 - 2022)

Sutro Biopharma has disclosed Interest Coverage Ratio across 6 years of filings, most recently posting 7.61 for Q3 2022.

• Interest Coverage Ratio for Q3 2022 came in at 7.61, up 82.01% year-over-year; the trailing twelve-month figure through Jun 2023 was 56.98 (down 19.22% YoY), and the FY2021 annual result was 31.41, down 80.2% from the prior year.
• Interest Coverage Ratio came in at 7.61 for Q3 2022 at Sutro Biopharma, up from 32.62 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 23.84 in Q2 2018 to a low of 59.56 in Q1 2022.
• The 5-year median for Interest Coverage Ratio is 12.3 (2019), against an average of 17.14.
• Across the five-year window, Interest Coverage Ratio surged 161.0% in 2020 and plunged 822.81% in 2021, its largest moves.
• Sutro Biopharma's Interest Coverage Ratio stood at 5.05 in 2018, then plunged by 458.55% to 18.09 in 2019, then jumped by 161.0% to 11.04 in 2020, then tumbled by 618.72% to 57.25 in 2021, then surged by 86.71% to 7.61 in 2022.
• The last three Interest Coverage Ratio figures came in at 7.61 (Q3 2022), 32.62 (Q2 2022), and 59.56 (Q1 2022), per Business Quant data.